Heidelberg Pharma AG
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Heidelberg Pharma AG
Dermatology-focused Almirall S.A. is partnering with Microsoft for generative artificial intelligence capabilities. It is the second generative AI-based collaboration announced by Almirall in several months.
While at least 25 accelerated approval cancer indications or drugs have been pulled or requested withdrawn since 2020, there has not yet been a similar concerted regulatory effort in the non-oncology space despite a large number of products with overdue postmarketing requirements.
Three UK medtech companies’ views on how their businesses will be influenced by external factors in the coming year.
Medtech SME Pennine Healthcare has a range of business challenges to navigate, but compliance with heightened environmental sustainability standards has rapidly risen up its list of priorities.
- Radiopharmaceuticals, Contrast Agents
- Large Molecule
- Other Names / Subsidiaries
- Heidelberg Pharma Research GmbH
- Wilex AG
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.